Cost Per Responder Analysis of Guselkumab Versus Certolizumab Pegol Using Efficacy Results from Pivotal Clinical Trials in Patients With Moderate to Severe Plaque Psoriasis. J of Skin 2018, 2, S80. https://doi.org/10.25251/skin.2.supp.81.